TheraSyn Bio, Inc.

TheraSyn Bio, Inc.

Biotechnology

Cambridge, Massachusetts 41 followers

A disruptive technology company targeting precision bioscience.

About us

TheraSyn Bio is a synthetic biology technology company providing precision bioscience solutions for our partners and service users. Our company develops proprietary platforms embedded with artificial intelligence methods to enhance precision medicine, environmental and sustainability solutions, industrial applications, and more.

Industry
Biotechnology
Company size
2-10 employees
Headquarters
Cambridge, Massachusetts
Type
Privately Held
Founded
2022
Specialties
Synthetic Biology, Precision Medicine, and Bioscience

Locations

Employees at TheraSyn Bio, Inc.

Updates

  • View organization page for TheraSyn Bio, Inc., graphic

    41 followers

    We are very excited about this partnership with The University of Memphis in advancing precision approaches to tackle challenging problems in intersecting areas of health. #precisionbio #syntheticbiology

    View organization page for The University of Memphis, graphic

    136,872 followers

    The University of Memphis and Massachusetts-based synthetic biology company TheraSyn Bio Inc. are partnering to advance synthetic biology research within the University’s biomedical, bioscience and computer science departments. Full Article Here: lnk.bio/uofmemphis

    • No alternative text description for this image
  • TheraSyn Bio, Inc. reposted this

    Join us for the TherSyn Bio Partnership event at the FedEx Institute of Technology! The bio-compounds and materials market is rapidly growing, driven by increasing consumer demand for sustainable and environmentally friendly products. According to a report by Grand View Research, the global bio-based market is expected to reach $30.7 billion by 2026. The market for bio-based synthetics is expected. By signing up you will better understand: 🔍 What to look for when teaming/partnering with industry for potential US Federal Government Grant and Contracting awards 🔍 The Synthetic Biology industry and its projected impact on the current and future global market from a sustainable health and economic perspective 🔍 Use Case Scenario Explorations 🔍 About platforms designing & developing precision bioscience tools that help overcome significant innovation areas. 🔍 How Artificial Intelligence adds to the Synthetic Biology market 🔍 Collaborative research opportunities for faculty, including a current team-building chance around a DARPA Biological Technologies call being pursued in partnership with UofM. To register, visit https://ow.ly/FG1150PZ4vi. November 7 | 3-5 PM Virtual

    • No alternative text description for this image

Similar pages